Sinopharm vaccine approved for emergency use: WHO

Estimated read time 5 min read

[vc_row el_class=”container section”][vc_column el_class=”row”][vc_row_inner el_class=”row”][vc_column_inner][expatmedia-landing-article title=”landing article”][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”col-md-8 “][vc_column_inner el_class=”col-md-8″][expatmedia-article-content body_text=”Nothing, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt.

Consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis.” byline=”staff reporter” caption=”Sinopharm has a 79 percent efficacy against Covid-19.” credits=”ARCHIVE”]

Sinopharm vaccine approved for emergency use: WHO

 

DUBAI – The Sinopharm vaccine has been approved for emergency use by the World Health Organisation (WHO).

“WHO gave emergency use listing to Sinopharm Beijing’s Covid-19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality,” WHO Director General Tedros Adhanom Ghebreyesus told a news conference on Friday (May 7).

“This expands the list of vaccines that Covax can buy and gives countries confidence to expedite their own regulatory approval and to import and administer a vaccine,” Ghebreyesus said.

WHO has previously given emergency approval to Covid-19 vaccines developed by Pfizer-BioNTech, AstraZeneca, Johnson & Johnson, and recently, Moderna.

Sinopharm is already being used in the UAE as part the country’s aggressive vaccination campaign against Covid-19. It is approved for use in more than 30 countries.

The Chinese-made vaccine is recommended for adults 18 years and older, and is administered in two doses, with a spacing of three to four weeks between each dose.

WHO’s Strategic Advisory Group of Experts on Immunisation reviewed Sinopharm and found it has 79 percent overall efficacy  against Covid-19.

In Abu Dhabi, a recent study found that Sinopharm is 100 percent effective against death, 93 percent effective in preventing hospitalisation and 95 percent effective against admission to intensive care.

In the UAE, Sinopharm goes under the brand name Hayat-Vax, as it is produced locally at the Ras Al Khaimah plant of drug manufacturer Julphar. ICA/Expat Media


For all the latest news from the UAE and the world, follow us on Facebook, Twitter and Instagram and subscribe to our YouTube page[/expatmedia-article-content][/vc_column_inner][vc_column_inner][expatmedia-related-posts enable_pagination=”no” layout=”2-col” posts_query=”size:6|order_by:date|post_type:post|categories:35″ title=”More Society Stories” thumb_size=”expatmedia-post-thumbnail”][/vc_column_inner][/vc_row_inner][vc_row_inner el_class=”col-md-4″][vc_column_inner][expatmedia-latest-posts read_more_text=”Read more →” posts_query=”size:10|order_by:date|post_type:post” title=”LATEST NEWS”][/vc_column_inner][vc_column_inner el_class=”border-box border-box-mwidth business–popular-ad”][expatmedia-guides-posts posts_query=”size:3|order_by:date|post_type:post|categories:35″ title=”POPULAR IN SOCIETY”][/vc_column_inner][vc_column_inner][expatmedia-html custom_content=”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”][expatmedia-subscription title=”Subscribe”][/vc_column_inner][vc_column_inner el_class=”border-box border-box-mwidth business–popular-ad”][expatmedia-guides-posts page_link=”http://expatmedia.net/guides/” posts_query=”size:3|order_by:date|post_type:post|categories:2″ title=”Guides”][/vc_column_inner][vc_column_inner][svc_social_stream twitter_type=”@” twitter_num=”4″ skin_type=”template” grid_columns_count_for_desktop=”vcyt-col-md-12″ grid_columns_count_for_tablet=”vcyt-col-sm-12″ grid_columns_count_for_mobile=”vcyt-col-xs-12″ excerpt_length=”150″ loadmore=”no” title=”Twitter Post” twitter_id=”ExpatMediaUAE”][vc_raw_html]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[/vc_raw_html][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row]

You May Also Like

More Stories

+ There are no comments

Add yours